Detection of carbapenemases based on susceptibility testing is complicated by the fact that bacteria carrying carbapenemases sometimes do not appear to be resistant to carbapenemases. This is especially true for OXA-48. The consequences may be that the appropriate treatment is not administered and that proper infection control measures are not implemented.

Using a molecular test to pinpoint the presence of carbapenemase genes is therefore essential for the accurate detection of carbapenemases. By identifying the genes involved, Check-MDR CT102 also enables you to quickly obtain information to guide infection control measures and helps you to create an overview of your resisstance situation.

Check-MDR CT102, which detects carbapenemases (KPC, NDM-1, VIM, IMP and OXA-48) as well as ESBLs (CTX-M, TEM and SHV), was found to have a sensitivity and specificity of 100%.

The evaluation is published ahead of print on the website of Journal of Clinical Microbiology. Click here to access the article.